Abstract
Timely fibrinogen replacement is key to treating critical hemorrhage. Measuring fibrinogen concentration by conventional laboratory tests requires centrifugation of blood samples and is often time-consuming. A point-of-care testing device (A&T, Yokohama, Japan), CG02N, has been available in Japan since 2011 to measure fibrinogen concentration without centrifugation. However, it has not been widely used as it requires dilution of blood samples using manual micropipetting. To further speed up and simplify the fibrinogen measurement, an improved device called FibCare (Atom Medical, Tokyo, Japan) was developed to avoid diluting blood samples. The purpose of this study is to verify the reliability of FibCare against laboratory measurement using the Clauss method. Fibrinogen concentrations with 60 sodium citrated whole blood samples were measured by both FibCare and Clauss methods in the laboratory. Measured values with the Clauss method were distributed in the 88–300 mg/dL range. By comparing these results, a significant positive correlation was observed between the FibCare and Clauss method (Y = 12.402 + 0.982 X; R = 0.891; P < 0.01). The study indicated that FibCare allows accurate measurement of fibrinogen concentration and shows a possibility to contribute to optimal fibrinogen replacement therapy during critical hemorrhage.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00540-021-02987-9/MediaObjects/540_2021_2987_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00540-021-02987-9/MediaObjects/540_2021_2987_Fig2_HTML.png)
Notes
POCT: point-of-care testing.
References
Hiippala ST, Myllyki GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg. 1995;81:360–5.
Hayakawa M, Gando S, Ono Y, Wada T, Yanagida Y, Sawamura A. Fibrinogen level deteriorates before other routine coagulation parameters and massive transfusion in the early phase of severe trauma: a retrospective observational study. Semin Thromb Hemost. 2015;41:35–42.
Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth. 2010;105:116–21.
Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, De Robertis E, Faraoni D, Filipescu DC, Fries D, Haas T, Jacob M, Lancé D, Pitarch JVL, Mallett S, Meier J, Molnar JZ, Rahe-Meyer N, Samama CM, Stensballe J, Van der Linden PJF, Wikkelsø AJ, Wouters P, Wyffels P, Zacharowski K. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur J Anaesthesiol. 2017;34:332–95.
Ogawa S, Tanaka KA, Nakajima Y, Nakayama Y, Takeshita J, Arai M, Mizobe T. Fibrinogen measurements in plasma and whole blood: a performance evaluation study of the dry-hematology system. Anesth Analg. 2015;120:18–25.
Hayakawa M, Gando S, Ono Y, Mizugaki A, Katabami K, Maekawa K, Miyamoto D, Wada T, Yanagida Y, Sawamura A. Rapid evaluation of fibrinogen levels using the CG02N whole blood coagulation analyzer. Semin Thromb Hemost. 2015;41:267–71.
Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, Sibony O, Mahieu-Caputo D, Hurtaud-Roux MF, Huisse MG, Denninger MH, de Prost D. PPH Study GroupThe decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5:266–73.
Katz R, Efremov V, Mooney C, El-Khuffash A, Heaphy L, Cosgrave D, Loughrey J, Thornton P. Assessment of the reliability and validity of a novel point-of-care fibrinogen (F-Point) device against an industry standard at fibrinogen levels >2 g/L in non-haemorrhage scenarios. Int J Obstet Anesth. 2020;43:91–6.
Funding
This study was partially funded by Atom Medical and A&T.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
This study has received financial and quality improvement support from Atom Medical and A&T. Atom Medical and A&T had no control over the interpretation of the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Okahara, S., Handoh, T., Wakita, M. et al. Fibrinogen measurement by a novel point-of-care device with whole blood: comparison of values against Clauss method. J Anesth 35, 757–760 (2021). https://doi.org/10.1007/s00540-021-02987-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-021-02987-9